MD Anderson and Rigel partner to expand olutasidenib evaluation in AML and other cancers

The University of Texas MD Anderson Cancer Center and Rigel Pharmaceuticals, Inc. today announced a multi-year strategic development collaboration to expand the evaluation of olutasidenib in acute myeloid leukemia (AML) and other hematologic cancers.

Cannabis Markets See Sales Plunge

New Cannabis Ventures offers readers this easy-to-read exclusive summary of BDSA’s monthly cannabis sales data for 11 states. Cannabis sales decreased 7.1% sequentially in January after

March 6, 2024

EU pharma trade body starts genomic profiling initiative to improve access

An illustration of the double helix. EUCOPE launched a genomic profiling initiative with pharma collaborators. Image Credit: Shutterstock / Immersion Imagery The European Confederation of

June 20, 2023

AI breakthrough: Speech analysis predicts Alzheimer’s progression with 78.5% accuracy

A method for predicting Alzheimer’s disease (AD) progression.

June 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.